查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594483

神經血管設備市場：按疾病病理學、設備和最終用戶分類 - 全球預測 2025-2030

Neurovascular Devices Market by Disease Pathology, Devices, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

神經血管設備市場2023年估值為32.1億美元，預計到2024年將達到34.4億美元，複合年成長率為7.34%，到2030年預計將達到52.8億美元。

神經血管設備市場包括用於診斷和治療影響大腦血管和脈管系統的疾病和病症的解決方案。由於中風和動脈瘤等腦血管疾病的增加，對創新治療技術的需求從未如此強烈。這些設備的應用範圍從支架和線圈系統等微創手術工具到準確疾病檢測所需的診斷設備。最終使用者主要是涉及神經血管疾病的醫院、專科診所和研究機構。神經系統疾病盛行率的增加、醫療技術的進步以及全球老年人口的增加等主要因素促進了市場的成長。其他影響因素包括新興國家意識的提高和醫療基礎設施的擴張。潛在的機會在於整合人工智慧和機器學習以增強診斷、遠端醫療平台以擴大患者覆蓋範圍，以及策略性進入亞太和拉丁美洲人口稀少的市場。然而，嚴格的監管合規和先進設備的高成本等挑戰是成長的主要障礙。研發投資有助於緩解這些挑戰，開發具有成本效益的解決方案並簡化監管途徑。創新的最佳途徑在於開發智慧神經血管干預措施，例如生物可吸收支架和下一代聚合物線圈，以及透過改進的資料分析和成像模式在患者特異性分析方面取得進展。這個市場的特點是技術進步快、競爭激烈，要求企業保持敏捷。因此，鼓勵公司專注於與醫療保健提供者的合作，以更好地適應最尖端科技，並對監管變化保持警惕，以保持競爭優勢。了解患者結果資料並不斷改進我們的產品是在這個動態環境中取得長期成功的基礎。

主要市場統計
基準年[2023] 32.1億美元
預測年份 [2024] 34.4億美元
預測年份 [2030] 52.8億美元
複合年成長率（%） 7.34%

市場動態：揭示快速發展的神經血管設備市場的關鍵市場洞察

供需的動態交互作用正在改變神經血管設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 腦動脈瘤和神經系統疾病的增加
    • 對微創腦部手術的需求不斷成長
  • 市場限制因素
    • 與神經血管介入和設備相關的高成本
  • 市場機會
    • 神經血管治療領域的新研究活動與技術進展
    • 正在進行的產品開發和神經血管設備核准
  • 市場挑戰
    • 全球神經外科醫師數量有限

波特五力：駕馭神經血管設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解神經血管設備市場的外部影響

外部宏觀環境因素在塑造神經血管設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解神經血管設備市場的競爭格局

對神經血管設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣神經血管設備市場供應商的績效評估

FPNV定位矩陣是評估神經血管設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃神經血管設備市場的成功之路

神經血管設備市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腦動脈瘤和神經系統疾病的發生率增加
      • 神經外科微創手術需求增加
    • 抑制因素
      • 與神經血管介入和設備相關的高成本
    • 機會
      • 神經血管治療領域的新研究活動與技術進展
      • 神經血管設備的持續產品開發和核准
    • 任務
      • 全世界的神經外科醫生數量有限。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章神經血管器材市場疾病病理

  • 動脈瘤
  • 動靜脈畸形和瘻管
  • 缺血性中風
  • 收縮

第7章神經血管設備市場（按設備）

  • 腦血管成形術和支架系統
    • 栓塞彈簧圈
    • 分流器
    • 液態栓塞劑
  • 腦栓塞及動脈瘤彈簧圈栓塞裝置
    • 頸動脈支架
    • 栓塞保護系統
  • 神經血栓切除裝置
    • 血栓清除裝置
    • 吸引裝置
    • 勒除器
  • 支撐裝置
    • 微導管
    • 微導管導引線

第8章神經血管設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第9章美洲神經血管設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太神經血管器械市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的神經血管設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Acandis GmbH
  • AngioDynamics Inc.
  • Artio Medical, Inc.
  • B. Braun Melsungen AG
  • BALT Group
  • Boston Scientific Corporation
  • Cerus Endovascular Inc.
  • CONMED Corporation
  • Cook Medical Group
  • Endologix Inc.
  • Evasc Medical Systems Corp.
  • Integra Lifesciences Corporation
  • iVascular SLU
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Medical Murray
  • Medtronic PLC
  • Microvention Inc.
  • Penumbra, Inc.
  • Phenox GmbH by Wallaby Medical
  • Rapid Medical Ltd.
  • Scientia Vascular, Inc.
  • Secant Group, LLC
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.
  • Zeus Company Inc.
Product Code: MRR-0360AB17E1FE

The Neurovascular Devices Market was valued at USD 3.21 billion in 2023, expected to reach USD 3.44 billion in 2024, and is projected to grow at a CAGR of 7.34%, to USD 5.28 billion by 2030.

The neurovascular devices market encompasses solutions designed to diagnose and treat diseases and conditions affecting the blood vessels and vascular structures in the brain. As a result of rising cerebrovascular incidents such as strokes and aneurysms, the necessity for innovative therapeutic technologies has never been greater. Applications of these devices span from minimally invasive surgical tools like stents and coil systems to diagnostic equipment necessary for accurate disease detection. End-users primarily include hospitals, specialized clinics, and research institutions engaged in neurovascular disorders. Market growth is fueled by key factors such as the increasing prevalence of neurological disorders, advancements in medical technology, and the growing geriatric population globally. Other influencing elements include rising awareness and the expansion of healthcare infrastructure in emerging economies. Potential opportunities lie in the integration of AI and machine learning for enhanced diagnostics, telemedicine platforms improving patient reach, and strategically entering underpenetrated markets in Asia-Pacific and Latin America. However, challenges such as stringent regulatory compliance and the high cost of advanced devices pose significant hurdles to growth. Investments in R&D can mitigate these challenges, helping develop cost-effective solutions and streamlining regulatory pathways. The best avenues for innovation lie in the development of smart neurovascular interventions, such as bioresorbable stents and next-gen polymer coils, as well as advancements in patient-specific analysis through data analytics and improved imaging methods. The nature of this market is characterized by rapid technological advancement and strong competition, requiring firms to remain agile. Therefore, businesses are advised to focus on collaboration with healthcare providers for better adaptation of cutting-edge technologies and to remain vigilant of regulatory changes to sustain a competitive advantage. Understanding patient outcome data and continuously improving product offerings will be fundamental to achieving long-term success in this dynamic landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 3.21 billion
Estimated Year [2024] USD 3.44 billion
Forecast Year [2030] USD 5.28 billion
CAGR (%) 7.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Devices Market

The Neurovascular Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of a brain aneurysm and neurological disorders
    • Rising demand for minimally invasive procedures for brain surgeries
  • Market Restraints
    • High cost associated with the neurovascular interventions and devices
  • Market Opportunities
    • Emerging research activities and technological advancements in the field of neurovascular therapies
    • Ongoing product development and approvals of neurovascular devices
  • Market Challenges
    • Limited availability of neurosurgeons across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Devices Market

A detailed market share analysis in the Neurovascular Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Devices Market

A strategic analysis of the Neurovascular Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, AngioDynamics Inc., Artio Medical, Inc., B. Braun Melsungen AG, BALT Group, Boston Scientific Corporation, Cerus Endovascular Inc., CONMED Corporation, Cook Medical Group, Endologix Inc., Evasc Medical Systems Corp., Integra Lifesciences Corporation, iVascular S.L.U., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medical Murray, Medtronic PLC, Microvention Inc., Penumbra, Inc., Phenox GmbH by Wallaby Medical, Rapid Medical Ltd., Scientia Vascular, Inc., Secant Group, LLC, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zeus Company Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Pathology, market is studied across Aneurysm, Arteriovenous Malformation & Fistulas, Ischemic Stroke, and Stenosis.
  • Based on Devices, market is studied across Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Neurothrombectomy Devices, and Support Devices. The Cerebral Angioplasty & Stenting Systems is further studied across Embolic Coils, Flow Diverters, and Liquid Embolic Agents. The Cerebral Embolization & Aneurysm Coiling Devices is further studied across Carotid Artery Stents and Embolic Protection Systems. The Neurothrombectomy Devices is further studied across Clot Retrieval Devices, Suction Devices, and Vascular Snares. The Support Devices is further studied across Micro Catheters and Micro Guidewires.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialized Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of a brain aneurysm and neurological disorders
      • 5.1.1.2. Rising demand for minimally invasive procedures for brain surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the neurovascular interventions and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities and technological advancements in the field of neurovascular therapies
      • 5.1.3.2. Ongoing product development and approvals of neurovascular devices
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of neurosurgeons across the globe
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurovascular Devices Market, by Disease Pathology

  • 6.1. Introduction
  • 6.2. Aneurysm
  • 6.3. Arteriovenous Malformation & Fistulas
  • 6.4. Ischemic Stroke
  • 6.5. Stenosis

7. Neurovascular Devices Market, by Devices

  • 7.1. Introduction
  • 7.2. Cerebral Angioplasty & Stenting Systems
    • 7.2.1. Embolic Coils
    • 7.2.2. Flow Diverters
    • 7.2.3. Liquid Embolic Agents
  • 7.3. Cerebral Embolization & Aneurysm Coiling Devices
    • 7.3.1. Carotid Artery Stents
    • 7.3.2. Embolic Protection Systems
  • 7.4. Neurothrombectomy Devices
    • 7.4.1. Clot Retrieval Devices
    • 7.4.2. Suction Devices
    • 7.4.3. Vascular Snares
  • 7.5. Support Devices
    • 7.5.1. Micro Catheters
    • 7.5.2. Micro Guidewires

8. Neurovascular Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialized Clinics

9. Americas Neurovascular Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurovascular Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurovascular Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acandis GmbH
  • 2. AngioDynamics Inc.
  • 3. Artio Medical, Inc.
  • 4. B. Braun Melsungen AG
  • 5. BALT Group
  • 6. Boston Scientific Corporation
  • 7. Cerus Endovascular Inc.
  • 8. CONMED Corporation
  • 9. Cook Medical Group
  • 10. Endologix Inc.
  • 11. Evasc Medical Systems Corp.
  • 12. Integra Lifesciences Corporation
  • 13. iVascular S.L.U.
  • 14. Johnson & Johnson Services, Inc.
  • 15. Koninklijke Philips N.V.
  • 16. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 17. Medical Murray
  • 18. Medtronic PLC
  • 19. Microvention Inc.
  • 20. Penumbra, Inc.
  • 21. Phenox GmbH by Wallaby Medical
  • 22. Rapid Medical Ltd.
  • 23. Scientia Vascular, Inc.
  • 24. Secant Group, LLC
  • 25. Stryker Corporation
  • 26. Terumo Corporation
  • 27. W. L. Gore & Associates, Inc.
  • 28. Zeus Company Inc.

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY EMBOLIC PROTECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY CLOT RETRIEVAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY MICRO GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NEUROVASCULAR DEVICES MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES NEUROVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY SUPPORT DEVICES, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND NEUROVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL ANGIOPLASTY & STENTING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY CEREBRAL EMBOLIZATION & ANEURYSM COILING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY NEUROVASCULAR DEVICES MARKET SIZE, BY NEUROTHROMBECT